Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

Corbus Pharmaceuticals Holdings, Inc. (CRBP)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsJun-30-23Jun-05-23Mar-31-23Mar-05-23Dec-31-22Dec-05-22Sep-30-22Sep-05-22
   10-Q8-K10-Q8-K10-K8-K10-Q8-K
Revenues  0.04.20.013.40.016.10.04.1
            Revenue growth   70.0% 307.4% -55.7%-100.0%-52.8%
Cost of goods sold  0.08.20.026.80.016.10.08.2
Gross profit  0.0-3.90.0-13.40.00.00.0-4.1
            Gross margin   -92.7% -100.0% 0.0% -99.1%
Selling, general and administrative   [+]3.93.93.93.94.618.74.14.1
Research and development  4.2 13.4 6.2 4.1 
Other operating expenses   0.3   16.1 0.0
EBITDA   [+]-8.0 -17.1 -10.6 -8.0 
            EBITDA margin   -192.7% -129.2% -215.9% -199.1%
Depreciation and amortization  0.2 0.2 0.2 0.2 
EBIT   [+]-8.2-8.2-17.3-17.3-10.8-34.8-8.2-8.2
            EBIT margin   -192.7% -129.2% -215.9% -199.1%
Non-recurring items   [+]     5.0  
Interest expense  0.80.80.70.70.62.10.50.5
Other income (expense), net   [+]0.20.20.20.30.6-0.4-0.1-0.1
Pre-tax income  -8.8-8.8-17.7-17.7-10.9-42.3-8.8-8.8
Income taxes  0.00.00.00.00.00.00.00.0
            Tax rate  0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income  -8.8-8.8-17.7-17.7-10.9-42.3-8.8-8.8
            Net margin   -206.7% -132.1% -262.4% -213.8%
   
Basic EPS   [+]($2.05)($2.05)($4.24)($4.23)($2.61)($10.15)($0.07)($0.07)
Diluted EPS   [+]($2.05)($2.05)($4.24)($4.23)($2.61)($10.15)($0.07)($0.07)
   
Shares outstanding (basic)   [+]4.34.34.24.24.24.2125.3125.3
Shares outstanding (diluted)   [+]4.34.34.24.24.24.2125.3125.3
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy